tiprankstipranks
Trending News
More News >
ClearPoint Neuro (CLPT)
NASDAQ:CLPT
US Market

ClearPoint Neuro (CLPT) Earnings Dates, Call Summary & Reports

Compare
319 Followers

Earnings Data

Report Date
Aug 12, 2025
TBA Not Confirmed
Period Ending
2025 (Q2)
Consensus EPS Forecast
-0.2
Last Year’s EPS
-0.16
Same Quarter Last Year
Based on 3 Analysts Ratings

Earnings Call Summary

Earnings Call Date:May 13, 2025
|
% Change Since: -14.93%
|
Next Earnings Date:Aug 12, 2025
Earnings Call Sentiment|Neutral
ClearPoint Neuro demonstrated solid revenue growth and expansion in its core segments, supported by successful capital funding. However, challenges remain with significant declines in capital equipment revenue and increased operating expenses. The company is investing in future growth, particularly in the biologics and drug delivery segment, but faces near-term financial pressures.
Company Guidance
In the recent investor call, ClearPoint Neuro provided extensive guidance on their strategic focus and financial performance. The company reported a total revenue of $8.5 million for Q1 2025, marking an 11% increase from $7.6 million in Q1 2024. The biologics and drug delivery sector grew by 9% to $4.7 million, driven by a $1.2 million increase in product revenue, despite a $0.8 million decrease in services. The neurosurgery navigation segment saw a remarkable 70% growth to $3.3 million, attributed to new product offerings and an expanded customer base. Conversely, capital equipment and software revenue decreased by 63% to $0.5 million. The gross margin improved slightly to 60%, while research and development costs surged by 29% to $3.4 million. Sales and marketing expenses rose by 17% to $3.8 million, and general and administrative expenses increased by 44% to $4.1 million. The company also highlighted securing foundational funding from Oberland Capital, enhancing its financial flexibility with $32 million in net proceeds and access to an additional $25 million in credit. This financial strategy aims to support ClearPoint Neuro's ambitious growth initiatives and the anticipated commercialization of cell and gene therapies.
Revenue Growth
Total revenue for Q1 2025 was $8.5 million, representing an 11% increase from Q1 2024's $7.6 million.
Biologics and Drug Delivery Revenue Increase
Revenue for biologics and drug delivery rose by 9% to $4.7 million in Q1 2025, fueled by a $1.2 million increase in product revenue.
Neurosurgery Navigation Revenue Surge
Neurosurgery navigation revenue increased by 70% to $3.3 million in Q1 2025, due to higher sales of new product offerings and an increased customer base.
Gross Margin Improvement
Gross margin for Q1 2025 was 60%, a 1% increase compared to 59% in Q1 2024.
Successful Capital Funding
ClearPoint Neuro secured foundational funding from Oberland Capital, providing flexibility with a new credit facility that includes $32 million net proceeds and potential for $25 million more.
Single Use Consumables Growth
Single use consumables business more than doubled with a 104% growth rate, driven by increased orders from biopharma partners and new product launches.

ClearPoint Neuro (CLPT) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

CLPT Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Aug 12, 2025
2025 (Q2)
-0.20 / -
-0.16
May 13, 2025
2025 (Q1)
-0.16 / -0.22
-0.16-37.50% (-0.06)
Feb 26, 2025
2024 (Q4)
-0.16 / -0.20
-0.18-11.11% (-0.02)
Nov 07, 2024
2024 (Q3)
-0.17 / -0.18
-0.210.00% (+0.02)
Aug 07, 2024
2024 (Q2)
-0.20 / -0.16
-0.2944.83% (+0.13)
May 07, 2024
2024 (Q1)
-0.19 / -0.16
-0.2330.43% (+0.07)
Mar 12, 2024
2023 (Q4)
-0.20 / -0.18
-0.180.00% (0.00)
Nov 09, 2023
2023 (Q3)
-0.25 / -0.20
-0.15-33.33% (-0.05)
Aug 08, 2023
2023 (Q2)
-0.19 / -0.29
-0.18-61.11% (-0.11)
May 11, 2023
2023 (Q1)
-0.19 / -0.23
-0.17-35.29% (-0.06)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

CLPT Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
May 13, 2025
$14.20$12.43-12.46%
Feb 26, 2025
$17.22$14.20-17.54%
Nov 07, 2024
$13.42$11.65-13.19%
Aug 07, 2024
$6.44$9.06+40.68%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does ClearPoint Neuro (CLPT) report earnings?
ClearPoint Neuro (CLPT) is schdueled to report earning on Aug 12, 2025, TBA Not Confirmed.
    What is ClearPoint Neuro (CLPT) earnings time?
    ClearPoint Neuro (CLPT) earnings time is at Aug 12, 2025, TBA Not Confirmed.
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is CLPT EPS forecast?
          CLPT EPS forecast for the fiscal quarter 2025 (Q2) is -0.2.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis